A Silver Bullet
for Brain Cancer
Treatment?
for Brain Cancer
Treatment?
Contact us today, and we'll help you receive the world's best anti-cancer treatments — scientifically proven and free of serious side effects.
Request a Free Consultation
I agree with terms of Privacy Policy
A Silver Bullet
for Brain Cancer
Treatment?
for Brain Cancer
Treatment?
Contact us today, and we'll help you receive the world's best anti-cancer treatments — scientifically proven and free of serious side effects.
Request a Free Consultation
The prospect of a brain cancer diagnosis can freeze many on their tracks. On average, only 35% of all people with brain cancer will survive five years – but it all depends on the type of cancer. Aggressive brain tumours, such as glioblastoma or diffuse intrinsic pontine glioma (DIPG) rarely respond to conventional methods and are almost never cured.
The prospect of a brain cancer diagnosis can freeze many on their tracks. On average, only 35% of all people with brain cancer will survive five years – but it all depends on the type of cancer. Aggressive brain tumours, such as glioblastoma or diffuse intrinsic pontine glioma (DIPG) rarely respond to conventional methods and are almost never cured.
I accept the terms of the Privacy Policy and agree to the processing of my personal information
OK
Get a free Consultation
Just type your contacts and message
How can we help?
Send us a message
Follow Up Call
Enter your details to receive a call back from us
Immunotherapy: Game-Changing Methods
1
Oncolytic Viruses are human-safe viruses with specific receptors that can penetrate and destroy cancer cells. They also increase the recognition of the tumor by the patient's own immune system.
3
Intratumoral Injections:
applying vaccines directly into the tumor by injection, either immediately after brain tumor removal surgery or via an Ommaya reservoir.
applying vaccines directly into the tumor by injection, either immediately after brain tumor removal surgery or via an Ommaya reservoir.
All methods are based on sound scientific data, and confirmed through extensive clinical trials involving the successful treatment of thousands of patients.
2
Personalized Cancer vaccines are made from the patient's cancer cells. Vaccines train the patient's immune system to recognize and destroy malignant cells, just as it does against infectious agents.
4
Allogeneic Targeted Activated Cancer Killer cells (ATACK) are donor killer cells that selectively destroy tumor tissue. ATACKs are powerful and targeted, so they work even when other methods are ineffective.
Immunotherapy: Game-Changing Methods
1
Oncolytic Viruses are human-safe viruses with specific receptors that can penetrate and destroy cancer cells. They also increase the recognition of the tumor by the patient's own immune system.
3
Intratumoral Injections:
applying vaccines directly into the tumor by injection, either immediately after brain tumor removal surgery or via an Ommaya reservoir.
applying vaccines directly into the tumor by injection, either immediately after brain tumor removal surgery or via an Ommaya reservoir.
All methods are based on sound scientific data, and confirmed through extensive clinical trials involving the successful treatment of thousands of patients.
2
Personalized Cancer Vaccines are made from the patient's cancer cells. Vaccines train the patient's immune system to recognize and destroy malignant cells, just as it does against infectious agents.
4
Allogeneic Targeted Activated Cancer Killer cells (ATACK) are donor killer cells that selectively destroy tumor tissue. ATACKs are powerful and targeted, so they work even when other methods are ineffective.
Netta’s Story: A Second Chance at Life
Netta, a mother of two, was the first patient in the world to be cured from a highly aggressive type of glioma by combining oncolytic viruses and immunotherapy. She was initially diagnosed in 2010 with anaplastic astrocytoma.
Netta then underwent emergency brain surgery, followed by radiation therapy and a long course of conventional chemotherapy. However, in 2015, the tumour returned.
Her doctors originally recommended a second brain surgery, which could leave her with a severe disability. She refused to take the risk and turned to Biotherapy International, where she got a combination of oncolytic virus and a personalized immunotherapy protocol. As of today, Netta remains cancer-free; her MRIs show no evidence of tumors, and she enjoys a fully active, healthy life.
Netta’s Story: A Second
Chance at Life
Chance at Life
Netta, a mother of two, was the first patient in the world to be cured from a highly aggressive type of glioma by combining oncolytic viruses and immunotherapy. She was initially diagnosed in 2010 with anaplastic astrocytoma.
Netta then underwent emergency brain surgery, followed by radiation therapy and a long course of conventional chemotherapy. However, in 2015, the tumour returned.
Her doctors originally recommended a second brain surgery, which could leave her with a severe disability. She refused to take the risk and turned to Biotherapy International, where she got a combination of oncolytic virus and a personalized immunotherapy protocol. As of today, Netta remains cancer-free; her MRIs show no evidence of tumors, and she enjoys a fully active, healthy life.
Prof. Shimon Slavin is regarded as one of the world-leading researchers in anti-cancer immunotherapy. The protocols he has designed have proven effective at activating the immune system, essentially “training” it to fight mutated cancer cells.
Throughout his career, he has published over 680 articles in scientific publications and four books.
Throughout his career, he has published over 680 articles in scientific publications and four books.
About Professor Shimon Slavin
Medical & Scientific Director of Biotherapy International
We propose innovative, out-of-the-box solutions to diseases deemed incurable by other experts.
Prof. Shimon Slavin is regarded as one of the world-leading researchers in anti-cancer immunotherapy. The protocols he has designed have proven effective at activating the immune system, essentially “training” it to fight mutated cancer cells.
Throughout his career, he has published over 680 articles in scientific publications and four books.
Throughout his career, he has published over 680 articles in scientific publications and four books.
About Professor Shimon Slavin
Medical & Scientific Director of Biotherapy International
We propose innovative, out-of-the-box solutions to diseases deemed incurable by other experts.
Frequently Asked Questions
It's impossible to promise a complete cure without knowing the case's specifics. The type of tumour, previous treatment, and the patient’s current clinical condition will all affect survival rates. However, at Biotherapy International, we have a proven record of achieving remission among patients with highly aggressive types of cancer, even after standard treatments such as surgery or radiotherapy have failed.
Yes, you can. Surgery, radiotherapy, and chemotherapy can often be very effective at shrinking a tumour to its smallest possible size. This is known as the "minimal residual disease" stage, meaning that tiny tumours may still be left behind – and, therefore, regrow. At this stage, immunotherapy has the best chance to produce a full, permanent recovery. Some of our special immunotherapy protocols specifically target these "minimal" tumours down to the last cancer cell.
At our cutting-edge facility, we specialize in treating a spectrum of aggressive brain tumors, including glioblastoma, anaplastic astrocytoma, and various gliomas. Our comprehensive approach and advanced therapies aim to provide personalized care, offering hope and healing to individuals facing these challenging diagnoses.
To provide you with specific details regarding the type of brain cancer treatments that would be suitable for you, we need more information about your medical history. Please contact us using the form below to arrange a consultation.
Frequently Asked Questions
It's impossible to promise a complete cure without knowing the case's specifics. The type of tumour, previous treatment, and the patient’s current clinical condition will all affect survival rates. However, at Biotherapy International, we have a proven record of achieving remission among patients with highly aggressive types of cancer, even after standard treatments such as surgery or radiotherapy have failed.
Yes, you can. Surgery, radiotherapy, and chemotherapy can often be very effective at shrinking a tumour to its smallest possible size. This is known as the "minimal residual disease" stage, meaning that tiny tumours may still be left behind – and, therefore, regrow. At this stage, immunotherapy has the best chance to produce a full, permanent recovery. Some of our special immunotherapy protocols specifically target these "minimal" tumours down to the last cancer cell.
At our cutting-edge facility, we specialize in treating a spectrum of aggressive brain tumors, including glioblastoma, anaplastic astrocytoma, and various gliomas. Our comprehensive approach and advanced therapies aim to provide personalized care, offering hope and healing to individuals facing these challenging diagnoses.
To provide you with specific details regarding the type of brain cancer treatments that would be suitable for you, we need more information about your medical history. Please contact us using the form below to arrange a consultation.
